Status: Recruiting
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
A multi-center, prospective, dual arm, randomized, controlled pivotal study to evaluate the safety and effectiveness of the ReGelTec HYDRAFIL™ System.
Participants needed: 225
Trial details
Age: 22-85Biological sex: AllType: InterventionalSponsor: ReGelTec, Inc.Updated: May 8, 2026Locations: 14
Eligibility criteria
Male or female subjects aged 22 to 85 years, inclusive [+7]
History of or active systemic or local infection [+35]